Since 2014
Ipertensione arteriosa, continuum cardiovascolare e ruolo clinico dei sartanii
Farmeconomia
View Archive Info| Field | Value | |
| Title |
Ipertensione arteriosa, continuum cardiovascolare e ruolo clinico dei sartanii
|
|
| Creator |
Destro, Maurizio
|
|
| Subject |
Pharmacoeconomics; Health economics
Cardiovascular continuum; Angiotensin II receptor blockers; Hypertension |
|
| Description |
The cardiovascular and cardiorenal continuum comprises the transition from cardiovascular risk factors to endothelial dysfunction and atherosclerosis, to chronic congestive heart failure, and-stage renal disease or premature death. RAAS (renin-angiotensin-aldosterone system) is involved in all steps along this pathway. Data from clinical studies involving valsartan and other ARBs provide evidence of the reduction of risk of cardiovascular events, and end-organ damage in the heart, kidneys and brain. This paper summarizes the status on research of ARBs based on clinical trials and regulatory approval.
|
|
| Publisher |
SEEd
|
|
| Date |
2011-03-15
|
|
| Type |
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion — |
|
| Format |
application/pdf
|
|
| Identifier |
http://journals.edizioniseed.it/index.php/FE/article/view/996
10.7175/fe.v12i1S.996 |
|
| Source |
Farmeconomia. Health economics and therapeutic pathways; Vol 12, No 1S (2011); 3-7
2240-256X 1721-6915 |
|
| Language |
eng
|
|
| Relation |
http://journals.edizioniseed.it/index.php/FE/article/view/996/1214
|
|